BCM
ETTX

Beryl Capital Management’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

Beryl Capital Management’s Portfolio ETTX Stock Details ETTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,131,772
Closed -$2.49M – 65
2022
Q2 		$2.49M Buy
+1,131,772
New +$2.26M 0.26% 37

Beryl Capital Management's ETTX Position: Q3 2022 in Review

Beryl Capital Management sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q3 2022, closing a stake of 1,131,772 shares — an estimated $2.49M sold.

Beryl Capital Management first reported a position in ETTX in Q2 2022 and held it in 1 quarter. The position peaked at $2.49M in Q2 2022. 0 funds tracked by Wall St. Rank hold ETTX as of Q3 2022.

  • Beryl Capital Management reported no remaining Entasis Therapeutics Holdings Inc. position as of Q3 2022 after selling out during the quarter.
  • Beryl Capital Management sold 1,131,772 Entasis Therapeutics Holdings Inc. shares in Q3 2022, an estimated $2.49M.
  • Beryl Capital Management first reported a position in Entasis Therapeutics Holdings Inc. in Q2 2022 and held it in 1 quarter.
  • Beryl Capital Management's Entasis Therapeutics Holdings Inc. position peaked at $2.49M in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q3 2022.

Based on Beryl Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.